DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
O'Brien S, Furman RR, Coutre S, Flinn IW, Burger JA, Blum K. et al.
Single-agent ibrutinib in treatment-naïve and relapsed/refractory chronic lymphocytic leukemia: a 5-year experience.
Blood 2018;
131: 1910-9
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.